Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis

Arthritis Research and Therapy

Volumn 12, Issue 2, 2010, Pages

  Palomino Morales, Rogelio J ^a   Vazquez Rodriguez, Tomas R ^b   Torres, Orlando ^a   Morado, Inmaculada C ^c   Castañeda, Santos ^d   Miranda Filloy, Jose A ^b   Callejas Rubio, Jose L ^e   Fernandez Gutierrez, Benjamin ^c   Gonzalez Gay, Miguel A ^f   Martin, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; METHYLPREDNISOLONE; PREDNISONE; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; GIANT CELL ARTERITIS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; BIOPSY; DRUG COMBINATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

BIOPSY; DRUG THERAPY, COMBINATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GIANT CELL ARTERITIS; HUMANS; INTERLEUKIN-18; LINKAGE DISEQUILIBRIUM; METHYLPREDNISOLONE; POLYMORPHISM, GENETIC; PREDNISONE; TOLL-LIKE RECEPTOR 4;

EID: 77956997912     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2962     Document Type: Article

References (64)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002, 347:261-271. 10.1056/NEJMra011913, 12140303.
2. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001, 27:729-749. 10.1016/S0889-857X(05)70232-5, 11723761.
3. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009, 61:1454-1461. 10.1002/art.24459, 19790127.
4. Weyand CM, Ma-Krupa W, Pryshchep O, Gröschel S, Bernardino R, Goronzy JJ. Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci 2005, 1062:195-208. 10.1196/annals.1358.023, 16461802.
5. Weyand CM, Goronzy JJ. The Dunlop-Dottridge Lecture: the pathogenesis of giant cell arteritis. J Rheumatol 2000, 27:517-522.
6. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003, 73:213-224. 10.1189/jlb.0602313, 12554798.
7. McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 2000, 21:312-315. 10.1016/S0167-5699(00)01648-0, 10871869.
8. Dinarello CA. Interleukin-18. Methods 1999, 19:121-132. 10.1006/meth.1999.0837, 10525448.
9. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001, 19:423-474. 10.1146/annurev.immunol.19.1.423, 11244043.
10. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001, 12:53-72. 10.1016/S1359-6101(00)00015-0, 11312119.
11. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998, 161:3400-3407.
12. Tominaga K, Yoshimoto T, Torigoe K, Kurimoto M, Matsui K, Hada T, Okamura H, Nakanishi K. IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol 2000, 12:151-160. 10.1093/intimm/12.2.151, 10653850.
13. Yoshimoto T, Mizutani H, Tsutsui H, Noben-Trauth N, Yamanaka K, Tanaka M, Izumi S, Okamura H, Paul WE, Nakanishi K. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 2000, 1:132-137. 10.1038/77811, 11248805.
14. Yoshimoto T, Tsutsui H, Tominaga K, Hoshino K, Okamura H, Akira S, Paul WE, Nakanishi K. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 1999, 96:13962-13966. 10.1073/pnas.96.24.13962, 24173, 10570181.
15. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003, 33:38-48. 10.1053/sarh.2002.50025, 12920695.
16. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. The HLA-DRB1 locus as a genetic component in giant cell arteritis: mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest 1992, 90:2355-2361. 10.1172/JCI116125, 443390, 1469092.
17. Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994, 37:514-520. 10.1002/art.1780370411, 8147928.
18. Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998, 25:2140-2145.
19. Mattey DL, Hajeer AH, Dababneh A, Thomson W, González-Gay MA, García-Porrúa C, Ollier WE. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 2000, 43:1749-1755. 10.1002/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K, 10943865.
20. Gonzalez-Gay MA, Rueda B, Vilchez JR, Lopez-Nevot MA, Robledo G, Ruiz MP, Fernández O, Garcia-Porrua C, Gonzalez-Escribano MF, Martín J. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis. Rheumatology 2007, 46:431-434. 10.1093/rheumatology/kel324, 17003171.
21. Jacobsen S, Baslund B, Madsen HO, Tvede N, Svejgaard A, Garred P. Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis. J Rheumatol 2002, 29:2148-21453.
22. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Amoli MM, Llorca J, Ollier WE. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol 2004, 22(6 Suppl 36):S18-S20.
23. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Mattey DL, Amoli MM, Thomson W, Ollier WE. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol 2002, 20:179-184.
24. Salvarani C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi G, Catanoso MG, Boiardi L. Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis. J Rheumatol 2005, 32:2173-2177.
25. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi G, Catanoso MG, Pattacini L, Salvarani C. Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheum 2006, 54:4011-4017. 10.1002/art.22218, 17133531.
26. Rueda B, Roibas B, Martin J, Gonzalez-Gay MA. Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. J Rheumatol 2007, 34:1535-1539.
27. Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, Farnetti E, Brini M, Portioli I. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J Rheumatol 2000, 27:1215-1221.
28. Salvarani C, Casali B, Nicoli D, Farnetti E, Macchioni P, Catanoso MG, Chen Q, Bajocchi G, Boiardi L. Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum 2003, 48:3219-3223. 10.1002/art.11307, 14613286.
29. Amoli MM, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA. Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. J Rheumatol 2003, 30:2019-2022.
30. Gonzalez-Gay MA, Oliver J, Sanchez E, Garcia-Porrua C, Paco L, Lopez-Nevot MA, Ollier WE, Martin J. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis. J Rheumatol 2005, 32:2178-2182.
31. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martín J, Gonzalez-Gay MA. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 2005, 32:1737-1741.
32. Morgan AW, Robinson JI, Barrett JH, Martin J, Walker A, Babbage SJ, Ollier WE, Gonzalez-Gay MA, Isaacs JD. Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res Ther 2006, 8:R109. 10.1186/ar1996, 1779375, 16846526.
33. Rueda B, Miranda-Filloy JA, Martin J, Gonzalez-Gay MA. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis. J Rheumatol 2008, 35:850-854.
34. Rodríguez-Pla A, Beaty TH, Savino PJ, Eagle RC, Seo P, Soloski MJ. Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis. Arthritis Rheum 2008, 58:1849-1853. 10.1002/art.23457, 18512818.
35. Nolan KF, Greaves DR, Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 1998, 51:161-163. 10.1006/geno.1998.5336, 9693051.
36. Higa S, Hirano T, Mayumi M, Hiraoka M, Ohshima Y, Nambu M, Yamaguchi E, Hizawa N, Kondo N, Matsui E, Katada Y, Miyatake A, Kawase I, Tanaka T. Association between interleukin-18 gene polymorphism 105A/C and asthma. Clin Exp Allergy 2003, 33:1097-1102. 10.1046/j.1365-2222.2003.01739.x, 12911784.
37. Imboden M, Nicod L, Nieters A, Glaus E, Matyas G, Bircher AJ, Ackermann-Liebrich U, Berger W, Probst-Hensch NM, . SAPALDIA Team The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic asthma: The SAPALDIA Cohort Study. Clin Exp Allergy 2006, 36:211-218. 10.1111/j.1365-2222.2006.02424.x, 16433859, SAPALDIA Team.
38. Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet DA, Barbaux S, Schnabel R, Bickel C, Espinola-Klein C, Poirier O, Perret C, Münzel T, Rupprecht HJ, Lackner K, Cambien F, Blankenberg S, . Athero Gene Investigators Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005, 112:643-650. 10.1161/CIRCULATIONAHA.104.519702, 16043644, Athero Gene Investigators.
39. Kretowski A, Mironczuk K, Karpinska A, Bojaryn U, Kinalski M, Puchalski Z, Kinalska I. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002, 51:3347-3349. 10.2337/diabetes.51.11.3347, 12401730.
40. Mojtahedi Z, Naeimi S, Farjadian S, Omrani GR, Ghaderi A. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabet Med 2006, 23:235-239. 10.1111/j.1464-5491.2006.01786.x, 16492204.
41. Sugiura T, Maeno N, Kawaguchi Y, Takei S, Imanaka H, Kawano Y, Terajima-Ichida H, Hara M, Kamatani N. A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population. Arthritis Res Ther 2006, 8:R60. 10.1186/ar1930, 1526617, 16563174.
42. Tamura K, Fukuda Y, Sashio H, Takeda N, Bamba H, Kosaka T, Fukui S, Sawada K, Tamura K, Satomi M, Yamada T, Yamamura T, Yamamoto Y, Furuyama J, Okamura H, Shimoyama T. IL18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol 2002, 37:111-116. 10.1007/s005350200133, 12572878.
43. Sivalingam SP, Yoon KH, Koh DR, Fong KY. Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens 2003, 62:498-504. 10.1046/j.1399-0039.2003.00137.x, 14617033.
44. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-8. 10.1002/art.1780330810, 2202311.
45. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001, 30:249-256. 10.1053/sarh.2001.16650, 11182025.
46. Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Morado IC, Castañeda S, Callejas-Rubio JL, Miranda-Filloy JA, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA. Association between Toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. J Rheumatol 2009, 36:1501-1506. 10.3899/jrheum.081286, 19531762.
47. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998, 25:1750-1755.
48. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, Llorca J. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004, 83:342-347. 10.1097/01.md.0000145369.25558.b5, 15525846.
49. Tone M, Thompson SA, Tone Y, Fairchild PJ, Waldmann H. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol 1997, 159:6156-6163.
50. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001, 112:146-152. 10.1016/S0165-5728(00)00407-0, 11108943.
51. PubMed. , http://www.ncbi.nlm.nih.gov/sites/entrez
52. Sánchez E, Palomino-Morales RJ, Ortego-Centeno N, Jiménez-Alonso J, González-Gay MA, López-Nevot MA, Sánchez-Román J, de Ramón E, González-Escribano MF, Pons-Estel BA, D'Alfonso S, Sebastiani GD, Alarcón-Riquelme ME, Martín J. Italian collaborative group Identification of a new putative IL18 gene variant through a functional and association study in systemic lupus erythematosus. Hum Mol Genet 2009, 18:3739-3748. 10.1093/hmg/ddp301, 19584085, Italian collaborative group.
53. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994, 121:484-491.
54. Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, Martin J, Llorca J. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore) 2005, 84:277-290. 10.1097/01.md.0000180043.19285.54, 16148728.
55. Thompson SR, Humphries SE. Interleukin-18 genetics and inflammatory disease susceptibility. Genes Immun 2007, 8:91-99. 10.1038/sj.gene.6364366, 17215860.
56. Nabili S, Bhatt P, Roberts F, Gracie A, McFadzean R. Local expression of IL-18 in the temporal artery does not correlate with clinical manifestations of giant cell arteritis. Neuro-Ophthalmology 2008, 32:3-6.
57. Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, Fukushima T, Takahashi R, Kuwahara H, Kita A, Oshima K, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004, 22:73-78. 10.1016/j.jaut.2003.10.001, 14709415.
58. Glas J, Torok HP, Tonenchi L, Kapser J, Schiemann U, Muller-Myhsok B, Folwaczny M, Folwaczny C. Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARDIS15/NOD2 genotype. Inflamm Bowel Dis 2005, 11:1031-1037. 10.1097/01.MIB.0000187574.41290.b1, 16306764.
59. Rueda B, González-Gay MA, Matarán L, López-Nevot MA, Martín J. Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis. Tissue Antigens 2005, 65:544-548. 10.1111/j.1399-0039.2005.00408.x, 15896202.
60. Rauzy O, Fort M, Nourhashemi F, Alric L, Juchet H, Ecoiffier M, Abbal M, Adoue D. Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis. Ann Rheum Dis 1998, 57:380-382. 10.1136/ard.57.6.380, 1752615, 9771216.
61. Guerne PA, Salvi M, Seitz M, Bruhlmann P, Rivier G, Frey D, Mermillod B, Vischer TL, Tiercy JM. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica: Swiss Group for Research on HLA in Polymyalgia Rheumatica. J Rheumatol 1997, 24:671-676.
62. Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P, Joosten LA, van Riel PL, Berg WB. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 2004, 50:999-1001. 10.1002/art.20114, 15022344.
63. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Devière J, Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299 gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004, 53:987-992. 10.1136/gut.2003.030205, 1774122, 15194649.
64. Pierangeli SS, Vega-Ostertag ME, Raschi E, Liu X, Romay-Penabad Z, De Micheli V, Galli M, Moia M, Tincani A, Borghi MO, Nguyen-Oghalai T, Meroni PL. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis 2007, 66:1327-1333. 10.1136/ard.2006.065037, 17261530.